Index by author

October 01, 2006; Volume 73,Issue 10

  1. Neustadt, David H.

    1. Intra-articular injections for osteoarthritis of the knee
      Intra-articular injections for osteoarthritis of the knee
      David H. Neustadt, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 897-911;

      If usual medical measures fail to control the pain of osteoarthritis of the knee, intra-articular injections of a corticosteroid, a hyaluronan, or both may help.

  2. Nicholls, Stephen J.

    1. Interpreting the ASTEROID Trial
      Ilke Sipahi, MD, Stephen J. Nicholls, MBBS, PhD, E. Murat Tuzcu, MD and Steven E. Nissen, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 937-944;

      The optimal strategy for lipid-lowering in patients with coronary artery disease may be to aim for the lowest low-density lipoprotein cholesterol level that can be attained without adverse effects.

  3. Nissen, Steven E.

    1. Interpreting the ASTEROID Trial
      Ilke Sipahi, MD, Stephen J. Nicholls, MBBS, PhD, E. Murat Tuzcu, MD and Steven E. Nissen, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 937-944;

      The optimal strategy for lipid-lowering in patients with coronary artery disease may be to aim for the lowest low-density lipoprotein cholesterol level that can be attained without adverse effects.

  4. Pezzetta, Francesca

    1. Are statins ‘smart bombs’? (August 2006)
      Luca Mascitelli, MD and Francesca Pezzetta, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 881;

  5. Shishehbor, Mehdi H.

    1. In reply: Are statins ‘smart bombs’? (August 2006)
      Mehdi H. Shishehbor, DO, MPH and Deepak L. Bhatt, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 881-884;

  6. Sipahi, Ilke

    1. Interpreting the ASTEROID Trial
      Ilke Sipahi, MD, Stephen J. Nicholls, MBBS, PhD, E. Murat Tuzcu, MD and Steven E. Nissen, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 937-944;

      The optimal strategy for lipid-lowering in patients with coronary artery disease may be to aim for the lowest low-density lipoprotein cholesterol level that can be attained without adverse effects.

  7. Tuzcu, E. Murat

    1. Interpreting the ASTEROID Trial
      Ilke Sipahi, MD, Stephen J. Nicholls, MBBS, PhD, E. Murat Tuzcu, MD and Steven E. Nissen, MD
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 937-944;

      The optimal strategy for lipid-lowering in patients with coronary artery disease may be to aim for the lowest low-density lipoprotein cholesterol level that can be attained without adverse effects.

  8. Widdice, Lea E.

    1. Using the new HPV vaccines in clinical practice
      Lea E. Widdice, MD and Jessica A. Kahn, MD, MPH
      Cleveland Clinic Journal of Medicine October 2006, 73 (10) 929-935;

      The new vaccines against human papillomavirus (HPV) could prevent up to 70% of cases of cervical cancer. But Pap testing will still be necessary.

« Previous (Pages : 1 2 ... 2)next »
Back to top

In this issue